Concurrent papillary thyroid carcinoma and incidental cervical lymph node indolent B cell non-Hodgkin lymphoma: clinicopathological features, outcomes, and potential relationships

The concurrent diagnosis of PTC and indolent CLN-B-NHL is extremely rare, with distinct clinicopathological and immunophenotypic features. A subset of cases exhibited coexisting PTC metastases and lymphoma within the same lymph node, though no direct molecular link (e.g., shared BCL2/IGH or CCND1/IGH alterations) was identified. Despite favorable treatment responses and 100% 5-year survival rate in this cohort, the small sample size limits definitive conclusions regarding long-term outcomes. Comprehensive pathological evaluation is critical for PTC with atypical lymph node involvement, and further studies are needed to validate the role of aggressive management in this population.

Authors

Institutions

Publication Details

Journal
World Journal of Surgical Oncology
Published
2025-04-21
DOI
https://doi.org/10.1186/s12957-025-03803-4
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Concurrent papillary thyroid carcinoma and incidental cervical lymph node indolent B cell non-Hodgkin lymphoma: clinicopathological features, outcomes, and potential relationships

Qiong-Li Zhai, Run-Fen Cheng, Yanhui Zhang, Yanyan Song
World Journal of Surgical Oncology
Lymphoma Diagnosis and Treatment
article

Concurrent papillary thyroid carcinoma and incidental cervical lymph node indolent B cell non-Hodgkin lymphoma: clinicopathological features, outcomes, and potential relationships

Qiong-Li Zhai, Run-Fen Cheng, Yanhui Zhang, Yanyan Song
article en

Abstract

The concurrent diagnosis of PTC and indolent CLN-B-NHL is extremely rare, with distinct clinicopathological and immunophenotypic features. A subset of cases exhibited coexisting PTC metastases and lymphoma within the same lymph node, though no direct molecular link (e.g., shared BCL2/IGH or CCND1/IGH alterations) was identified. Despite favorable treatment responses and 100% 5-year survival rate in this cohort, the small sample size limits definitive conclusions regarding long-term outcomes. Comprehensive pathological evaluation is critical for PTC with atypical lymph node involvement, and further studies are needed to validate the role of aggressive management in this population.

World Journal of Surgical OncologyVol. 23(1)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Institute of Hematology & Blood Diseases Hospital (CN)
Good health and well-being
Openalex Percentile: Top 88%
Lymphoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.